UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reporting recommendations for tumor marker prognostic studies

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9067-9072

2005

Volltextzugriff (PDF)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

JNCI : Journal of the National Cancer Institute, 2005-08, Vol.97 (16), p.1180-1184

2005

Volltextzugriff (PDF)

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Breast cancer research and treatment, 2006-11, Vol.100 (2), p.229-235

2006

Volltextzugriff (PDF)

Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib

Molecular oncology, 2008-04, Vol.1 (4), p.406-412

Clark, Gary M.

2008

Volltextzugriff (PDF)

Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2350-2357

2008

Volltextzugriff (PDF)

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

Breast cancer research : BCR, 2004-01, Vol.6 (3), p.R149-R156, Article R149

2004

Volltextzugriff (PDF)

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3238-3247

2004

Volltextzugriff (PDF)

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

Journal of clinical oncology, 2003-05, Vol.21 (10), p.1973-1979

2003

Volltextzugriff (PDF)

Effects of Smoking on the Pharmacokinetics of Erlotinib

Clinical cancer research, 2006-04, Vol.12 (7), p.2166-2171

2006

Volltextzugriff (PDF)

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

Modern pathology, 2004-12, Vol.17 (12), p.1545-1554

2004

Volltextzugriff (PDF)

Prognostic Factors in Breast Cancer

Archives of pathology & laboratory medicine (1976), 2000-07, Vol.124 (7), p.966-978

2000

Volltextzugriff (PDF)

Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial

Journal of clinical oncology, 2022-06, Vol.40 (18), p.2004-2012

2022

Volltextzugriff (PDF)

Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype

Clinical cancer research, 2006-09, Vol.12 (17), p.5047-5054

2006

Volltextzugriff (PDF)

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Journal of clinical oncology, 2023-03, Vol.41 (7), p.1331-1338

2023

Volltextzugriff (PDF)

Hazard rates of recurrence following diagnosis of primary breast cancer

Breast cancer research and treatment, 2005, Vol.89 (2), p.173-178

2005

Volltextzugriff (PDF)

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Journal of clinical oncology, 2005-08, Vol.2 (8), p.416-422

2005

Volltextzugriff (PDF)

Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive margins

European archives of oto-rhino-laryngology, 2020-04, Vol.277 (4), p.1155-1165

2020

Volltextzugriff (PDF)

Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

JNCI : Journal of the National Cancer Institute, 2003-03, Vol.95 (5), p.353-361

2003

Volltextzugriff (PDF)

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

Breast cancer research and treatment, 1998-01, Vol.52 (1-3), p.227-237

1998

Volltextzugriff (PDF)

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Clinical cancer research, 2021-10, Vol.27 (20), p.5472-5481

2021

Volltextzugriff (PDF)

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1474-1481

1999

Volltextzugriff (PDF)

REporting recommendations for tumour MARKer prognostic studies (REMARK)

European journal of cancer (1990), 2005-08, Vol.41 (12), p.1690-1696

2005

Volltextzugriff (PDF)

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

JNCI : Journal of the National Cancer Institute, 2009-11, Vol.101 (21), p.1453-1463

2009

Volltextzugriff (PDF)

Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

JNCI : Journal of the National Cancer Institute, 2000-04, Vol.92 (7), p.550-556

2000

Volltextzugriff (PDF)

Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer

Cancer research (Chicago, Ill.), 2002-11, Vol.62 (22), p.6510-6518

2002

Volltextzugriff (PDF)

1 – 25 von 1.656

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.444)
Mit Volltextzugriff
(1.389)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.654)
Japanisch
(1)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(952)
EZB Electronic Journals Library
(735)
Journals@Ovid Complete
(613)
Publisher or Other Site
(601)
Ingenta
(590)
Elsevier ScienceDirect Journals Complete
(300)
IngentaConnect Journals
(206)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(185)
Wiley Journals
(182)
Springer journals
(141)
Wiley Online Library Full Collection 2018
(126)
Oxford Journals Online Current
(120)
American Physical Society Journals
(113)
PROLA - Physical Review Online Archive
(96)
JSTOR
(93)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(88)
Oxford Journals 2020 Medicine
(86)
Nature Journals
(78)
SAGE Complete
(49)
Taylor & Francis
(48)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Reporting recommendations for tumor marker prognostic studies

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib

Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

Effects of Smoking on the Pharmacokinetics of Erlotinib

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

Prognostic Factors in Breast Cancer

Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial

Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Hazard rates of recurrence following diagnosis of primary breast cancer

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive margins

Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

REporting recommendations for tumour MARKer prognostic studies (REMARK)

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer

Suchergebnisse filtern